Tissue/Organ

Aspect Biosystems talks regeneration

Finding out what’s behind the $20m bioprinting start-up. Vancouver-based Aspect Biosystems recently closed a $20 million funding round, making it one of the world’s most...

Innovating organ-on-chip to accelerate research

BIOFABICS brings custom design tools to biofabrication. While still in its infancy, organ-on-chip (OOC) technology is quickly becoming a key growth segment in the Longevity...

Aspect Biosystems raises $20m for human bioprinting

Further boost for 3D bio-printing sector as Aspect Biosystems announces a multimillion funding round for advanced therapies. Biotechnology company and pioneer in the 3D printing...

Xenotransplant pigs organs one-step closer

Scientists are moving closer to creating first human transplant organs from pigs. More than 100,000 people are on the organ transplant waiting list in the US...

AI-built “living machine” is world first

Evolved by AI algorithms from frog cells into something not remotely Kermit-like, this living machine is a real leap forward for Longevity. Forget everything you...

Mini livers can be printed within 90 days

A new study suggests mini livers can be successfully printed in the laboratory within 90 days. This could have profound implications for transplant patients...

Supporting research and organ growth. Literally

Manchester BIOGEL to start providing kits for tissue growth as the company scales-up in 2020. Another of the interesting companies we encountered at the 3D...

Healios to fast-track pluripotent stem cell therapy

Healios K.K. to bring its novel regenerative pluripotent stem cell treatments to market through accelerated Japanese approvals process. Stem cell pioneers Healios KK will use...

2020 outlook for Longevity technology

Will 2020 be the year that sees a step change in Longevity? We review technology readiness levels for key Longevity domains. Yep, we have a...

Final frontier – 3D bioprinting in space

A strategic partnership between CELLINK and Made in Space promises advances for drug screening and cancer treatments. CELLINK, a Swedish bioprinter manufacturer, has announced a...

University of Minho to spin out bioprinting start-up

Research developments create a company focused on meniscus regeneration; seed funding planned for early 2020. One of the leading speakers at the recent 3D Bioprinting...

The Pentagon and Longevity tech opportunities

A released Pentagon report identifies research in areas with Longevity application - tech is moving fast and makes for intriguing reading. The US Military has...

New hydrogel advances Longevity applications

Hydrogels have been used in everything from contact lenses to babies’ nappies. Now, scientists have made a breakthrough which could pave the way for...

Organoids will attract bigger investment in 2020

Mini organs set for maximum success as new models can be used to individualise cancer therapy. Organoids are three-dimensional bundles of cells grown in culture...

AgeX expects promising Longevity future

In its end of year letter to shareholders, AgeX Therapeutics sees a bright future for the Longevity market. Longevity.Technology: The days when aging was considered...

Bioelectronics set to hit $10bn within 5 years

The growth in neural technology and cybernetic start-ups will fuel M&A activity between next year and the end of 2025. Neuralink, a company which is...

Pig-monkey chimeras in biomedical breakthrough

In a world first, pig-monkey chimeras have survived to full term in what could be a breakthrough for organ transplantation. The idea of creating a...

AgeX and Lineage granted pluripotent patent

AgeX Therapeutics and Lineage Cell Therapeutics awarded US patent for 'Method of Generating Induced Pluripotent Stem Cells'. AgeX Therapeutics, Inc. and Lineage Cell Therapeutics, Inc. today announced...

Interview: 3D bioprinting realties and timescales

After a unique 3D bioprinting research symposium in London we chat with UCL's expert: Dr Deepak Kalaskar  There's something about being at conferences with early-stage...

Exclusive: Interview with US presidential candidate

Zoltan Istvan to challenge Trump in 2020; solving Longevity is at the top of his agenda. Last week, the transhumanist activist Zoltan Istvan announced his...

Latest articles

Combining existing medicines to target aging

Rejuvenate Biomed closes in on €9 million funding round for human trials of sarcopenia-targeted combined drug. Already well-known for its beer and bureaucracy to its...

Stem cells could identify new treatments for Parkinson’s

Scientists believe they may have made a significant leap forward in the fight against Parkinson’s disease with the discovery of cells which could help...

Longevity marketing and the need for clarity

Dr Oliver Zolman makes the case for Longevity companies adopting a checklist when it comes to making anti-aging claims. When it comes to marketing in...

The interferons are coming to senolytic aging therapies

A new report suggests that studying the relationship between interferons and senescence could be key to developing new anti-aging therapies.  There are some things which...